Showing posts with label Infinity Pharma. Show all posts
Showing posts with label Infinity Pharma. Show all posts

Wednesday, May 11, 2011

Ratings on (JPM) (GMR) (HTHT) (INFI) (IVR) Reiterated

Ratings on JPMorgan Chase & Co. (NYSE: JPM), General Maritime Co. (NYSE: GMR), China Lodging Group (NASDAQ: HTHT), Infinity Pharmaceuticals Inc (NASDAQ: INFI) and Invesco Mortgage Capital Inc (NYSE: IVR) were reiterated by analysts.

Morgan Stanley (NYSE:MS) reiterated an “overweight” rating on JPMorgan Chase & Co. (JPM). They have a price target of $61.00 on the company.

Dahlman Rose reiterated a “hold” rating on General Maritime Co. (GMR).

Oppenheimer reiterated an “outperform” rating on China Lodging Group (HTHT). They have a price target of $27.00 on the company.

Jefferies (NYSE:JEF) reiterated a “buy” rating on Infinity Pharmaceuticals Inc (INFI). They have a price target of $8.00 on the company.

Wunderlich reiterated a “buy” rating on Invesco Mortgage Capital Inc (IVR).

Monday, May 9, 2011

Ratings on (HP) (INFI) (LUV) (MAIN) (MLR) Upgraded

Analysts upgraded their ratings on Helmerich & Payne (NYSE: HP), Infinity Pharmaceuticals Inc (NASDAQ: INFI), Southwest Airlines Co. (NYSE: LUV), Main Street Capital Co. (NASDAQ: MAIN) and Miller Industries, Inc. (NYSE: MLR) today.

Duncan Williams upgraded Helmerich & Payne (HP) from a “reduce” rating to a “strong buy” rating. They have a price target of of $72.00 on the company. They cited valuation as the catalyst behind the call.

Piper Jaffray upgraded Infinity Pharmaceuticals Inc (INFI) from a “neutral” rating to an “overweight” rating. They have a price target of $9.00 on the company, up from $6.00.

Dahlman Rose upgraded Southwest Airlines Co. (LUV) from a “hold” rating to a “buy” rating. They have a price target of $15.00 on the company.

Ladenburg Thalmann upgraded Main Street Capital Co. (MAIN) from a “neutral” rating to a “buy” rating. They have a price target of $19.50 on the company, up from $17.75.

Bank of America (NYSE:BAC) upgraded Miller Industries, Inc. (MLR). They have a price target of $53.00 on the company, up from $46.00.